Our findings, derived from clinical tissue microarrays, single-cell and bulk sequencing, and mechanistic experiments, suggest EMP1 is involved in PC metastasis via the PI3K/AKT signaling pathway, offering insights into potential novel therapeutic strategies and personalized treatment for PC patients. This evidence concerns the gene EMP1 and pachyonychia congenita.